FDA Adverse Event Injury Summary report: N

VALIANT STENT GRAFT

MDR report key: 13175654 · Received January 6, 2022

Report

Report Number
9612164-2022-00081
Event Type
Injury
Date Received
January 6, 2022
Date of Event
July 7, 2021
Report Date
January 6, 2022
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC RECEIVED THE FOLLOWING INFORMATION OBTAINED FROM THE JOURNAL ARTICLE ENTITLED; INTRAOPERATIVE STENT-GRAFT-INDUCED AORTIC INTIMAL INTUSSUSCEPTION DURING TEVAR FOR TYPE B AORTIC DISSECTION MA ET AL, JOURNAL OF ENDOVASCULAR THERAPY 2021, VOL. 28(6) 860¿870. DOI: 10.1177/15266028211028213. EXACT DATE OF IMPLANT UNKNOWN. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

VALIANT STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF TYPE B AORTIC DISSECTIONS (TBAD) ON UNKNOWN DATES. THE FOLLOWING ADVERSE EVENTS WERE REPORTED: INTRAOPERATIVE STENT-GRAFT (SG)-INDUCED AORTIC INTIMAL INTUSSUSCEPTION (ISAII)/DISSECTION AND INTESTINAL ISCHEMIA. THE CAUSE OF THE ADVERSE EVENTS ARE UNDETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
739572 VALIANT STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR MIH MEDTRONIC IRELAND UNK-CV-SR-VALIANT

Patients

Seq Age Sex Outcome Treatment
1 55 YR Male Required Intervention